General Biopsy Tray with Lidocaine HCL Injection subject to sterility recall
Argon Medical Devices is recalling General Biopsy Tray kits containing Lidocaine HCL Injection because the kits do not meet sterility release criteria.
The agency’s classification
FDA (Devices): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as Class I. Per the rubric, FDA Class I recalls are never scored below 4. Sterility failure in an injectable medical device presents a significant risk of infection and adverse health consequences.
Plain-English summary
Argon Medical Devices, Inc. is recalling General Biopsy Tray kits (REF: GUTS1000) that contain Lidocaine HCL Injection USP 1% 10mg/mL in 5mL ampules. The kits do not meet the required release criteria for sterility.
The recalled product was distributed nationwide in the United States, including Puerto Rico, as well as to Trinidad and Tobago. The affected product quantity is 1,800 units with the code GUTS1000/20886333001594:00886333001590 and lot expiration date of 3/31/2028.
Patients and healthcare providers who have received this product should not use it. Contact Argon Medical Devices, Inc. for instructions on returns or proper disposal. Consult with your healthcare provider if you have questions about your medical care related to this product.
The recalled product
- Product
- General Biospy Tray, REF: GUTS1000
- Manufacturer
- Argon Medical Devices, Inc
- Affected units
- 1,800
Distribution
Part of a larger recall action
This product is one of 6 recalled by Argon Medical Devices, Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Argon Medical Devices, Inc
See all →- HighPeripherally Inserted Central Catheters Recalled Due to Hub Leaking and Cracking Risk
FDA (Devices) · 2026-08-05
- HighMidline Catheter Recalled Over Risk of Leaking or Cracking at Hub
FDA (Devices) · 2026-08-05
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereBone Marrow Tray kits recalled due to sterility failure
FDA (Devices) · 2026-07-22
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- ModerateMedline Convenience Kits with Lidocaine Ampules Recalled for Quality Issues
FDA (Devices) · 2026-07-08
- HighBone Marrow Biopsy Tray with Lidocaine Hydrochloride Recalled for Temperature Abuse
FDA (Drugs) · 2022-06-15
- ModerateMedline Circumcision Trays recalled due to Lidocaine quality issues
FDA (Devices) · 2026-07-08
- ModerateMedline Convenience Kits Block Tray recalled due to quality defects
FDA (Devices) · 2026-07-08
- HighIntegra Bone Marrow Biopsy Trays Recalled Due to Lidocaine Particulate
FDA (Devices) · 2015-11-04
- SevereKRS Global Biotechnology Recalls Lidocaine and Hyaluronidase Syringes for Sterility Concerns
FDA (Drugs) · 2019-10-09